Preliminary proteomic analysis of radiation response markers in rectal cancer patients
W.-Q. Shen, G.-Q. Rong, Y. Wu, Y.-W. Pu, Z.-Y. Ye, C. Cao, X.-D. Yang, C.-G. Xing Department of General Surgery, the Second Affiliated Hospital of Soochow University, Suzhou, China. xingcg@126.com
OBJECTIVE: To provide biomarkers related to the radiation response of patients to avoid unnecessary side effects on those who were not sensitive to radiotherapy.
PATIENTS AND METHODS: In the present study, we compared the different four proteins (PDIA3, Vimentin, Galectin3, Dhe3) patterns in rectal tumor tissue before and after radiation therapy by using 2-D PAGE, mass spectrometry, and bioinformatics analysis.
RESULTS: The protein level of Galectin3 and PDIA3 were downregulated in rectal cancer patients before and after radiotherapy (1.42 folds); while Dhe3 protein and Vimentin were upregulated (1-2 folds), and we also revealed Vimentin as its role in the negative regulation of the well-known transcription factor ATF4.
CONCLUSIONS: Our study showed that four candidate proteins, including PIDA3, Galectin3, Dhe3, and Vimentin, might be the potential biomarkers in the identification of radiation response in rectal cancer.
![Creative Commons License](https://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
W.-Q. Shen, G.-Q. Rong, Y. Wu, Y.-W. Pu, Z.-Y. Ye, C. Cao, X.-D. Yang, C.-G. Xing
Preliminary proteomic analysis of radiation response markers in rectal cancer patients
Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 20
Pages: 8841-8851
DOI: 10.26355/eurrev_201910_19279